Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Goldman Sachs
GS
|
+$540M |
| 2 |
Citizens Financial Group
CFG
|
+$304M |
| 3 |
Analog Devices
ADI
|
+$303M |
| 4 |
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
|
+$293M |
| 5 |
Travelers Companies
TRV
|
+$281M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$548M |
| 2 |
Micron Technology
MU
|
+$461M |
| 3 |
Citigroup
C
|
+$334M |
| 4 |
Broadcom
AVGO
|
+$319M |
| 5 |
AbbVie
ABBV
|
+$267M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.99% |
| 2 | Financials | 5.48% |
| 3 | Industrials | 4.89% |
| 4 | Consumer Discretionary | 4.88% |
| 5 | Healthcare | 4.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SCMP
6676
CALL
DELISTED
Sucampo Pharmaceuticals, Inc.
SCMP
| $155K | ﹤0.01% |
+13,100
| New | +$147K |
|
|
AWP
6677
abrdn Global Premier Properties Fund
AWP
$367M
| $154K | ﹤0.01% |
7,765
+668
| +9% | +$13K |
|
6678
New Mountain Finance
NMFC
$732M
| $154K | ﹤0.01% |
+10,778
| New | +$153K |
|
6679
CALL
American Superconductor
AMSC
$1.59B
| $153K | ﹤0.01% |
+33,600
| New | +$130K |
|
|
BRFS
6680
DELISTED
BRF SA
BRFS
| $153K | ﹤0.01% |
+10,645
| New | +$139K |
|
6681
PUT
Novavax
NVAX
$1.31B
| $153K | ﹤0.01% |
6,695
+320
| +5% | +$7.16K |
|
6682
CALL
Ocular Therapeutix
OCUL
$2.02B
| $153K | ﹤0.01% |
24,700
-17,000
| -41% | -$109K |
|
|
I
6683
DELISTED
INTELSAT S. A.
I
| $153K | ﹤0.01% |
32,587
+15,913
| +95% | +$60.1K |
|
|
JMBA
6684
CALL
DELISTED
Jamba, Inc.
JMBA
| $153K | ﹤0.01% |
17,700
+4,500
| +34% | +$39.9K |
|
|
BCIC
6685
BCP Investment Corp
BCIC
$92.9M
| $152K | ﹤0.01% |
4,155
+1,488
| +56% | +$51.1K |
|
|
ATCO
6686
PUT
DELISTED
Atlas Corp.
ATCO
| $152K | ﹤0.01% |
21,400
-39,000
| -65% | -$268K |
|
|
OMED
6687
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
| $152K | ﹤0.01% |
33,587
-12,410
| -27% | -$50.3K |
|
6688
PUT
Costamare
CMRE
$1.77B
| $151K | ﹤0.01% |
24,500
-19,400
| -44% | -$126K |
|
6689
PUT
OFG Bancorp
OFG
$2.21B
| $151K | ﹤0.01% |
+16,500
| New | +$157K |
|
|
PNNT
6690
Pennant Park Investment Corp
PNNT
$241M
| $151K | ﹤0.01% |
20,135
-15,276
| -43% | -$115K |
|
|
CCEC
6691
Capital Clean Energy Carriers
CCEC
$1.35B
| $151K | ﹤0.01% |
6,166
-12
| -0.2% | -$304 |
|
|
KND
6692
CALL
DELISTED
Kindred Healthcare
KND
| $151K | ﹤0.01% |
22,200
-268,100
| -92% | -$2.28M |
|
6693
CALL
Talphera
TLPH
$74.2M
| $150K | ﹤0.01% |
+1,630
| New | +$102K |
|
6694
CALL
Direxion Daily FTSE China Bear 3X ETF
YANG
$89.2M
| $150K | ﹤0.01% |
100
-6
| -6% | -$10.1K |
|
|
MEET
6695
PUT
DELISTED
The Meet Group, Inc. Common Stock
MEET
| $150K | ﹤0.01% |
41,300
-3,200
| -7% | -$13.6K |
|
|
VG
6696
CALL
DELISTED
Vonage Holdings Corporation
VG
| $150K | ﹤0.01% |
18,400
-6,500
| -26% | -$48.9K |
|
6697
CALL
Citizens
CIA
$192M
| $149K | ﹤0.01% |
20,300
-5,500
| -21% | -$42.4K |
|
6698
PUT
8x8 Inc
EGHT
$332M
| $149K | ﹤0.01% |
11,000
-10,900
| -50% | -$148K |
|
6699
CALL
NeoGenomics
NEO
$2.13B
| $149K | ﹤0.01% |
+13,400
| New | +$130K |
|
6700
Ooma
OOMA
$604M
| $149K | ﹤0.01% |
14,108
-94,494
| -87% | -$832K |
|
Similar funds
Citadel Advisors's Q3 2017 Portfolio in Review
As of Q3 2017, Citadel Advisors held 8,628 positions worth $130B, up 10% from $118B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Citadel Advisors's Q3 2017 filing shows 1,223 new, 3,315 increased, 2,707 reduced and 1,164 closed positions. Its largest new stake was Goldman Sachs: 2,394,331 shares worth $568M. The largest sale was Visa, an estimated $548M.
By sector, the portfolio is most concentrated in Technology at 7% of assets, down from 7.1% a quarter earlier, followed by Financials and Industrials.
- Citadel Advisors's largest Q3 2017 buy was Goldman Sachs: 2,394,331 shares worth $568M.
- Citadel Advisors added most to Citizens Financial Group in Q3 2017, an estimated $304M increase.
- Citadel Advisors's biggest Q3 2017 reduction was Visa, cutting an estimated $548M.
- Citadel Advisors fully exited Citigroup in Q3 2017, selling an estimated $334M.
- Citadel Advisors's ten largest holdings make up 17% of its $130B portfolio in Q3 2017.
- Citadel Advisors opened 1,223 new positions and closed 1,164 in Q3 2017.
- Citadel Advisors's portfolio value rose 10% quarter-over-quarter to $130B.
Based on Citadel Advisors's 13F filing for Q3 2017, filed 9 Nov 2017.